BridgeBio Pharma Inc (BBIO)
28.57
+0.80
(+2.88%)
USD |
NASDAQ |
Dec 24, 12:26
BridgeBio Pharma Cash and Short Term Investments (Quarterly): 266.32M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Pfizer Inc | 9.952B |
Alnylam Pharmaceuticals Inc | 2.780B |
Cassava Sciences Inc | 148.98M |
Regeneron Pharmaceuticals Inc | 9.796B |
Vertex Pharmaceuticals Inc | 6.524B |